Schedule 13G ownership disclosure

Kitov Pharmaceuticals Holdings Ltd.

Security class unavailable · CUSIP: 49803V107

Event date: 2018-05-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
541,600
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-18-000678
Form type
SC 13G/A
Filer
PURPLE BIOTECH LTD.
CIK
CIK 1614744
Filed
May 15, 2018
Reporting period
May 14, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub